The Healthcare Cost and Utilization Project (HCUP) Kids' Inpatient Database (KID) is the largest publicly available all-payer pediatric inpatient care database in the United States, containing data from two to three million hospital stays each year. Its large sample size is ideal for developing national and regional estimates and enables analyses of rare conditions, such as congenital anomalies, as well as uncommon treatments, such as organ transplantation. Developed through a Federal-State-Industry partnership sponsored by the Agency for Healthcare Research and Quality, HCUP data inform decision making at the national, State, and community levels. The KID is a sample of pediatric discharges from 4,000 U.S. hospitals in the HCUP State Inpatient Databases yielding approximately two to three million unweighted hospital discharges for newborns, children, and adolescents per year. About 10 percent of normal newborns and 80 percent of other neonatal and pediatric stays are selected from each hospital that is sampled for patients younger than 21 years of age. The KID contains clinical and resource use information included in a typical discharge abstract, with safeguards to protect the privacy of individual patients, physicians, and hospitals (as required by data sources). It includes discharge status, diagnoses, procedures, patient demographics (e.g., sex, age), expected source of primary payment (e.g., Medicare, Medicaid, private insurance, self-pay, and other insurance types), and hospital charges and cost. Restricted access data files are available with a data use agreement and brief online security training.

Abstract

The National (Nationwide) Kids' Inpatient Database (KID) is part of a family of databases and software tools developed for the Healthcare Cost and Utilization Project (HCUP). Only years 2003, 2006, 2009, 2012 are available on the PHS Data Portal.

The Kids' Inpatient Database (KID) is the largest publicly available all-payer pediatric inpatient care database in the United States, containing data from two to three million hospital stays. Its large sample size is ideal for developing national and regional estimates and enables analyses of rare conditions, such as congenital anomalies, as well as uncommon treatments, such as organ transplantation. KID releases for data years 1997, 2000, 2003, 2006, 2009, 2012, 2016, and 2019 are available for purchase online through the Online HCUP Central Distributor. The KID was not produced for 2015 because of the transition from ICD-9-CM to ICD-10-CM/PCS coding.

Usage

KID Database Documentation includes:

• Description of KID Database
• Restrictions on Use
• Files Specifications and Load Programs
• Data Elements
• Additional Resources for Data Elements
• ICD-10-CM/PCS Included in 2016 KID
• Information on Change to KID Design in 2000
• Known Data Issues
• KID Supplemental Files
• HCUP Tools: Labels and Formats
• Obtaining HCUP Data

%3C!-- --%3E

Documentation

Please visit the HCUP National KID page for more information.

This dataset tracks the updates made on the dataset "HCUP Kids' Inpatient Database (KID) - Restricted Access File" as a repository for previous versions of the data and metadata.

The Agency for Healthcare Research and Quality (AHRQ, formerly the Agency for Health Care Policy and Research) maintains the Healthcare Cost and Utilization Project (HCUP). HCUP is a Federal-State-industry partnership to build a standardized, multi-State health data system. AHRQ has taken the lead in developing HCUP databases, Web-based products, and software tools and making them available for restricted access public release.

HCUP comprises a family of administrative longitudinal databases-including State-specific hospital-discharge databases and a national sample of discharges from community hospitals.

HCUP databases contain patient-level information compiled in a uniform format with privacy protections in place. * The Nationwide Inpatient Sample (NIS) includes inpatient data from a national sample (about 20% of U.S. community hospitals) including roughly 7 million discharges from about 1,000 hospitals. It is the largest all-payer inpatient database in the U.S.; data are now available from 1988-1998. The NIS is ideal for developing national estimates, for analyzing national trends, and for research that requires a large sample size. * The State Inpatient Databases (SID) cover individual data sets in community hospitals from 22 participating States that represent more than half of all U.S. hospital discharges. The data have been translated into a uniform format to facilitate cross-State comparisons. The SID are particularly well-suited for policy inquiries unique to a specific State, studies comparing two or more States, market area research, and small area variation analyses.

• The State Ambulatory Surgery Databases (SASD) contain data from ambulatory care encounters in 9 participating States. The SASD capture surgeries performed on the same day in which patients are admitted and released form hospital- affiliated ambulatory surgery sites. The SASD are well suited for research that requires complete enumeration of hospital-based ambulatory surgeries within market areas and States.

• The project's newest restricted access public release is the Kids' Inpatient Database (KID), containing hospital inpatient stays for children 18 years of age and younger. Researchers and policymakers can use the KID to identify, track, and analyze national trends in health care utilization, access, charges, quality, and outcomes. The KID is the only all-payer inpatient care database for children in the U.S. It contains data from approximately 1.9 million hospital discharges for children. The data are drawn from 22 HCUP 1997 State Inpatient Databases and include a sample of pediatric general discharges from over 2,500 U.S. community hospitals (defined as short-term, non-Federal, general and specialty hospitals, excluding hospital units of other institutions). A key strength of the KID is that the large sample size enables analyses of both common and rare conditions; uncommon treatments, and organ transplantation. The KID also includes charge information on all patients, regardless of payer, including children covered by Medicaid, private insurance, and the uninsured.

  HCUP also contains powerful, user-friendly software that can be used with both HCUP data and with other administrative databases. The AHRQ has developed three powerful software tools Quality Indicators (QIs), Clinical Classification Software (CCS) and HCUPnet. See more on the agency's webpages.

Percentages are NI inclusive values, with NI restricted values given in parentheses.ap-Value of a Mantel-Haenszel chi-square test for all patients with NI.bRace/ethnicity testing not performed because of the extent of missing data.

IntroductionDual diagnosis (DD) with traumatic brain injury (TBI) and spinal cord injury (SCI) poses clinical and rehabilitation challenges. While comorbid TBI is common among adults with SCI, little is known about the epidemiology in the pediatric population. The primary objective of this study was to evaluate the prevalence of TBI among children in the United States hospitalized with SCI. Secondary objectives were to compare children hospitalized with DD with those with isolated SCI with regards to age, gender, race, hospital length of stay, and hospital charges.MethodsA retrospective analysis of hospital discharges among children aged 0–18 years occurring between 2016–2018 from U.S. hospitals participating in the Kids’ Inpatient Database. ICD-10 codes were used to identify cases of SCI, which were then categorized by the presence or absence of comorbid TBI.Results38.8% of children hospitalized with SCI had a co-occurring TBI. While DD disproportionately occurred among male children (67% of cases), when compared with children with isolated SCI, those with DD were not significantly more likely to be male. They were more likely to be Caucasian. The mean age of children with DD (13.2 ± 5.6 years) was significantly less than that of children with isolated SCI (14.4 ± 4.3 years). DD was associated with longer average lengths of stay (6 versus 4 days) and increased mean total hospital charges ($124,198 versus $98,089) when compared to isolated SCI.ConclusionComorbid TBI is prevalent among U.S. children hospitalized with SCI. Future research is needed to better delineate the impact of DD on mortality, quality of life, and functional outcomes.

Additional file 1. The three editions of ICD-10 codes for renal disease of CKD.

BackgroundRespiratory syncytial virus (RSV) causes significant pediatric morbidity and is the most common cause of bronchiolitis. Bronchiolitis hospitalizations declined among US infants from 2000‒2009; however, rates in infants at high risk for RSV have not been described. This study examined RSV and unspecified bronchiolitis (UB) hospitalization rates from 1997‒2012 among US high-risk infants.MethodsThe Kids’ Inpatient Database (KID) infant annual RSV (ICD-9 079.6, 466.11, 480.1) and UB (ICD-9 466.19, 466.1) hospitalization rates were estimated using weighted counts. Denominators were based on birth hospitalizations with conditions associated with high-risk for RSV: chronic perinatal respiratory disease (chronic lung disease [CLD]); congenital airway anomalies (CAA); congenital heart disease (CHD); Down syndrome (DS); and other genetic, metabolic, musculoskeletal, and immunodeficiency conditions. Preterm infants could not be identified. Hospitalizations were characterized by mechanical ventilation, inpatient mortality, length of stay, and total cost (2015$). Poisson and linear regression were used to test statistical significance of trends.ResultsRSV and UB hospitalization rates were substantially elevated for infants with higher-risk CHD, CLD, CAA and DS without CHD compared with all infants. RSV rates declined by 47.0% in CLD and 49.7% in higher-risk CHD infants; no other declines in high-risk groups were observed. UB rates increased in all high-risk groups except for a 22.5% decrease among higher-risk CHD. Among high-risk infants, mechanical ventilation increased through 2012 to 20.4% and 13.5% of RSV and UB hospitalizations; geometric mean cost increased to $31,742 and $25,962, respectively, and RSV mortality declined to 0.9%.ConclusionsAmong high-risk infants between 1997 and 2012, RSV hospitalization rates declined among CLD and higher-risk CHD infants, coincident with widespread RSV immunoprophylaxis use in these populations. UB hospitalization rates increased in all high-risk groups except higher-risk CHD, suggesting improvement in the health status of higher-risk CHD infants, potentially due to enhanced surgical interventions. Mechanical ventilation use and RSV and UB hospitalization costs increased while RSV mortality declined.

Background:
The Millennium Cohort Study (MCS) is a large-scale, multi-purpose longitudinal dataset providing information about babies born at the beginning of the 21st century, their progress through life, and the families who are bringing them up, for the four countries of the United Kingdom. The original objectives of the first MCS survey, as laid down in the proposal to the Economic and Social Research Council (ESRC) in March 2000, were:

• to chart the initial conditions of social, economic and health advantages and disadvantages facing children born at the start of the 21st century, capturing information that the research community of the future will require
• to provide a basis for comparing patterns of development with the preceding cohorts (the National Child Development Study, held at the UK Data Archive under GN 33004, and the 1970 Birth Cohort Study, held under GN 33229)
• to collect information on previously neglected topics, such as fathers' involvement in children's care and development
• to focus on parents as the most immediate elements of the children's 'background', charting their experience as mothers and fathers of newborn babies in the year 2000, recording how they (and any other children in the family) adapted to the newcomer, and what their aspirations for her/his future may be
• to emphasise intergenerational links including those back to the parents' own childhood
• to investigate the wider social ecology of the family, including social networks, civic engagement and community facilities and services, splicing in geo-coded data when available

Additional objectives subsequently included for MCS were:

• to provide control cases for the national evaluation of Sure Start (a government programme intended to alleviate child poverty and social exclusion)
• to provide samples of adequate size to analyse and compare the smaller countries of the United Kingdom, and include disadvantaged areas of England

Further information about the MCS can be found on the Centre for Longitudinal Studies web pages.

The content of MCS studies, including questions, topics and variables can be explored via the CLOSER Discovery website.

The first sweep (MCS1) interviewed both mothers and (where resident) fathers (or father-figures) of infants included in the sample when the babies were nine months old, and the second sweep (MCS2) was carried out with the same respondents when the children were three years of age. The third sweep (MCS3) was conducted in 2006, when the children were aged five years old, the fourth sweep (MCS4) in 2008, when they were seven years old, the fifth sweep (MCS5) in 2012-2013, when they were eleven years old, the sixth sweep (MCS6) in 2015, when they were fourteen years old, and the seventh sweep (MCS7) in 2018, when they were seventeen years old. End User Licence versions of MCS studies:
The End User Licence (EUL) versions of MCS1, MCS2, MCS3, MCS4, MCS5, MCS6 and MCS7 are held under UK Data Archive SNs 4683, 5350, 5795, 6411, 7464, 8156 and 8682 respectively. The longitudinal family file is held under SN 8172.

Sub-sample studies:
Some studies based on sub-samples of MCS have also been conducted, including a study of MCS respondent mothers who had received assisted fertility treatment, conducted in 2003 (see EUL SN 5559). Also, birth registration and maternity hospital episodes for the MCS respondents are held as a separate dataset (see EUL SN 5614).


How to access genetic and/or bio-medical sample data from a range of longitudinal surveys:
For information on how to access biomedical data from MCS that are not held at the UKDS, see the CLS Genetic data and biological samples webpage.

Secure Access datasets:
Secure Access versions of the MCS have more restrictive access conditions than versions available under the standard End User Licence or Special Licence (see 'Access data' tab above).

Secure Access versions of the MCS include:

• detailed sensitive variables not available under EUL. These have been grouped thematically and are held under SN 8753 (socio-economic, accommodation and occupational data), SN 8754 (self-reported health, behaviour and fertility), SN 8755 (demographics, language and religion) and SN 8756 (exact participation dates). These files replace previously available studies held under SNs 8456 and 8622-8627
  
• detailed geographical identifier files which are grouped by sweep held under SN 7758 (MCS1), SN 7759 (MCS2), SN 7760 (MCS3), SN 7761 (MCS4), SN 7762 (MCS5 2001 Census Boundaries), SN 7763 (MCS5 2011 Census Boundaries), SN 8231 (MCS6 2001 Census Boundaries), SN 8232 (MCS6 2011 Census Boundaries), SN 8757 (MCS7), SN 8758 (MCS7 2001 Census Boundaries) and SN 8759 (MCS7 2011 Census Boundaries). These files replace previously available files grouped by geography SN 7049 (Ward level), SN 7050 (Lower Super Output Area level), and SN 7051 (Output Area level)
• linked education administrative datasets for Key Stages 1, 2, 4 and 5 held under SN 8481 (England). This replaces previously available datasets for Key Stage 1 (SN 6862) and Key Stage 2 (SN 7712)
  
• linked education administrative datasets for Key Stage 1 held under SN 7414 (Scotland)
• linked education administrative dataset for Key Stages 1, 2, 3 and 4 under SN 9085 (Wales)
  
• linked NHS Patient Episode Database for Wales (PEDW) for MCS1 – MCS5 held under SN 8302
• linked Scottish Medical Records data held under SNs 8709, 8710, 8711, 8712, 8713 and 8714;
• Banded Distances to English Grammar Schools for MCS5 held under SN 8394
• linked Health Administrative Datasets (Hospital Episode Statistics) for England for years 2000-2019 held under SN 9030
• linked Health Administrative Datasets (SAIL) for Wales held under SN 9310
  
• linked Hospital of Birth data held under SN 5724.

The linked education administrative datasets held under SNs 8481,7414 and 9085 may be ordered alongside the MCS detailed geographical identifier files only if sufficient justification is provided in the application.

Researchers applying for access to the Secure Access MCS datasets should indicate on their ESRC Accredited Researcher application form the EUL dataset(s) that they also wish to access (selected from the MCS Series Access web page).

The Millennium Cohort Study: Linked Health Administrative Data (Scottish Medical Records), Inpatient and Day Care Attendance, 2000-2015: Secure Access includes data files from the NHS Digital Hospital Episode Statistics database for those cohort members who provided consent to health data linkage in the Age 50 sweep, and had ever lived in Scotland. The Scottish Medical Records database contains information about all hospital admissions in Scotland. This study concerns the Scottish Birth Records.

Other datasets are available from the Scottish Medical Records database, these include:

• Child Health Reviews (CHR) held under SN 8709
• Prescribing Information System (PIS) held under SN 8710
• Scottish Immunisation and Recall System (SIRS) held under SN 8711
• Scottish Birth Records (SMR11) held under SN 8712
• Outpatient Attendance (SMR00) held under <a href="https://beta.ukdataservice.ac.uk/datacatalogue/studies/study?id=8714"

To compare the time to asthma-related readmission between children admitted to the intensive care unit (ICU) for asthma and those with a non-ICU hospitalization in the United States and to explore risk factors associated with readmission among children admitted in the ICU. In this retrospective cohort study, we included children aged 2–17 years in the State Inpatient Database (2005-2014) from four U.S. states who were hospitalized for asthma. We compared the time to asthma-related readmissions and emergency department (ED) visit between children admitted and not admitted to the ICU using the log-rank test. Among those admitted to the ICU, we explored factors associated with readmission using Cox regression. 66 835 children were hospitalized for asthma, with 14.0% admitted to the ICU, and 12 844 were readmitted for asthma while 22 915 had an asthma-related ED visit. The time to asthma-related readmission was shorter in the ICU group compared to the non-ICU group (p 

ABSTRACT Objectives: Describe a predictive model of hospitalization frequency for children and adolescents with chronic disease. Methods: A decision tree-based model was built using a database of 141 children and adolescents with chronic disease admitted to a federal public hospital; 18 variables were included and the frequency of hospitalization was defined as the outcome. Results: The decision tree obtained in this study could properly classify 80.85% of the participants. Model reading provided an understanding that situations of greater vulnerability such as unemployment, low income, and limited or lack of family involvement in care were predictors of a higher frequency of hospitalization. Conclusions: The model suggests that nursing professionals should adopt prevention actions for modifiable factors and authorities should make investments in health promotion for non-modifiable factors. It also enhances the debate about differentiated care to these patients.

Background: Hemolytic uremic syndrome (HUS) is a complex disease with multi-organ involvement. Eculizumab therapy is recommended for treatment of complement mediated hemolytic uremic syndrome (cHUS). However, there are few studies evaluating eculizumab therapy among children with HUS. The primary objectives of the study were to describe and identify factors associated with eculizumab therapy in children with HUS.Design/Methods: This large, retrospective, multi-center, cohort study used the Pediatric Health Information System (PHIS) database to identify the index HUS-related hospitalization among patients ≤18 years of age from September 23, 2011 (Food and Drug Administration approval date of eculizumab) through December 31, 2018. Multivariate analysis was used to identify independent factors associated with eculizumab therapy during or after the index hospitalization.Results: Among 1,885 children included in the study, eculizumab therapy was noted in 167 children with a median age of 3.99 years (SD ± 4.7 years). Eculizumab therapy was administered early (within the first 7 days of hospitalization) among 65% of children who received the drug. Mortality during the index hospitalization among children with eculizumab therapy was 4.2 vs. 3.0% without eculizumab therapy (p = 0.309). Clinical factors independently associated with eculizumab therapy were encephalopathy [odds ratio (OR) = 3.09; p ≤ 0.001], seizure disorder (OR = 2.37; p = 0.006), and cardiac involvement (OR = 6.36, p < 0.001).Conclusion(s): Only 8.9% of children received eculizumab therapy. Children who presented with neurological and cardiac involvement with severe disease were more likely to receive eculizumab therapy, and children who received therapy received it early during their index hospitalization. Further prospective studies are suggested to confirm these findings.

Comparison of the characteristics of hospitalization episodes in children under five years of age with a diagnosis of respiratory syncytial virus, as per their admission to the PICU.

Characteristics of children under 5 years of age admitted to the hospital with a diagnosis of respiratory syncytial virus grouped per periods.

Comparison between children under five years of age hospitalized with a diagnosis of respiratory syncytial virus, with or without comorbidities.

Analysis of hospitalization episodes with a diagnosis of respiratory syncytial virus in children under one year of age.

Abbreviations: HAI, hospitalized airway infections; USD, United States dollar.*children who were admitted due to lower airway infections when they were younger than 3 years old.ap < 0.01 vs. control group.bp < 0.01 vs. other HAI group.Subsequent hospitalization and ambulatory visit frequencies and expenses in the enrolled children at age 3 to 10 years.

The geographic distribution of 27 children’s hospitals in the FUTang Updating medical REcords (FUTURE) database.

Factors associated to pediatric intensive care unit admission among children diagnosed with respiratory syncytial virus.

Characteristics of infants and children